FDA has announced one guidance specified in the imaging study, “Clinical Trial Imaging Endpoint Process Standards” in 2018. We’re going to introduce this guidance with 2 videos. In this Part 1, you can learn about the overview of this guidance.
Please feel free to contact us
We provide comprehensive, end‑to‑end clinical development support, with imaging at its core.
With more than 20 years of experience, our team of imaging specialists in Japan and around the world tackles the complex challenges of imaging evaluation in pharmaceutical and medical device development. We deliver optimal, project‑specific solutions for each client.